Pines Wealth Management LLC Invests $51,000 in agilon health, inc. (NYSE:AGL)

Pines Wealth Management LLC purchased a new stake in shares of agilon health, inc. (NYSE:AGL) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 26,750 shares of the company’s stock, valued at approximately $51,000.

Several other large investors have also recently added to or reduced their stakes in AGL. Rhumbline Advisers raised its holdings in shares of agilon health by 24.3% during the second quarter. Rhumbline Advisers now owns 433,019 shares of the company’s stock worth $2,832,000 after purchasing an additional 84,573 shares during the period. XTX Topco Ltd acquired a new position in shares of agilon health in the 2nd quarter valued at about $211,000. Simplify Asset Management Inc. bought a new stake in shares of agilon health during the 2nd quarter valued at about $659,000. Ensign Peak Advisors Inc raised its stake in agilon health by 43.5% during the second quarter. Ensign Peak Advisors Inc now owns 140,937 shares of the company’s stock worth $922,000 after acquiring an additional 42,750 shares during the period. Finally, Bank of Montreal Can bought a new position in agilon health in the second quarter worth about $404,000.

Insider Activity at agilon health

In related news, Director John William Wulf acquired 45,000 shares of the business’s stock in a transaction on Thursday, December 5th. The shares were purchased at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now owns 206,133 shares in the company, valued at approximately $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Karen Mcloughlin acquired 25,000 shares of agilon health stock in a transaction on Friday, December 13th. The shares were purchased at an average cost of $2.20 per share, with a total value of $55,000.00. Following the completion of the purchase, the director now directly owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. This represents a 51.90 % increase in their position. The disclosure for this purchase can be found here. Insiders acquired a total of 90,000 shares of company stock valued at $198,100 over the last ninety days. Insiders own 3.20% of the company’s stock.

agilon health Stock Up 2.9 %

Shares of AGL stock opened at $2.83 on Thursday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The stock has a market cap of $1.17 billion, a PE ratio of -3.01 and a beta of 0.53. The business’s fifty day moving average is $2.07 and its 200-day moving average is $3.68. agilon health, inc. has a 1 year low of $1.50 and a 1 year high of $7.73.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. During the same quarter last year, the firm posted ($0.06) earnings per share. Equities analysts expect that agilon health, inc. will post -0.52 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. Stifel Nicolaus dropped their price target on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research report on Tuesday, November 12th. Citigroup raised agilon health from a “sell” rating to a “neutral” rating and increased their target price for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Royal Bank of Canada reissued an “outperform” rating and set a $3.00 price target on shares of agilon health in a report on Tuesday, November 19th. Sanford C. Bernstein boosted their target price on shares of agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research note on Wednesday. Finally, JMP Securities cut shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Two equities research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $4.03.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.